119th Congress · introduced in the Senate · May 21, 2025
Right to Treat Act
Official title from Congress.gov
Latest action (Mar 19, 2026): Committee on Health, Education, Labor, and Pensions. Hearings held.
View on Congress.govPolicy area: Health
Congressional Research Service summary, version: Introduced in Senate (May 21, 2025)
Right to Treat Act
This bill specifies that no federal agency has the authority to regulate the practice of medicine. It further specifies that no federal law or policy may prohibit or restrict prescriptions for an unapproved (i.e., off-label) use of a drug approved by the Food and Drug Administration.
The bill does not affect any federal restrictions on specified topics, including abortion, assisted suicide, and gender transition.
No cosponsors.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Committee on Health, Education, Labor, and Pensions. Hearings held.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Actions from Congress.gov, newest first.
Administrative law and regulatory procedures · Centers for Disease Control and Prevention (CDC) · Department of Health and Human Services · Food and Drug Administration (FDA) · Health care coverage and access · National Institutes of Health (NIH) · Prescription drugs
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
No matching lobbying reports found within coverage